---
title: "ΜΑΡΚΟΣ ΓΕΡΑΣΟΠΟΥΛΟΣ — Ownership Dossier"
canonical: https://whiteintel.dev/entity/de35b41b-c5c3-5b63-94c8-2fcc15501566
json: https://whiteintel.dev/api/public/dossier/de35b41b-c5c3-5b63-94c8-2fcc15501566
jurisdiction: CY
source: WhiteIntel corporate-ownership graph
---

# ΜΑΡΚΟΣ ΓΕΡΑΣΟΠΟΥΛΟΣ

**Type:** Person  
**Jurisdiction:** CY  
**Canonical dossier:** https://whiteintel.dev/entity/de35b41b-c5c3-5b63-94c8-2fcc15501566  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/de35b41b-c5c3-5b63-94c8-2fcc15501566  

## Ownership & control

### Holdings / subsidiaries

- **AVENTIS PHARMA  ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ ΑΕΒΕ** (Director) — https://whiteintel.dev/entity/f779d72c-2767-5249-83e0-1918bcaca150

## Provenance

- cyprus_drcor — https://data.gov.cy/en/dataset/1026

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ΜΑΡΚΟΣ ΓΕΡΑΣΟΠΟΥΛΟΣ**. Human view: https://whiteintel.dev/entity/de35b41b-c5c3-5b63-94c8-2fcc15501566 · Structured JSON: https://whiteintel.dev/api/public/dossier/de35b41b-c5c3-5b63-94c8-2fcc15501566._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._